karen Kotloff
karen Kotloff
University of Maryland School of Medicine
Verified email at medicine.umaryland.edu
Title
Cited by
Cited by
Year
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
KL Kotloff, JP Nataro, WC Blackwelder, D Nasrin, TH Farag, ...
The Lancet 382 (9888), 209-222, 2013
25982013
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
KL Kotloff, JP Winickoff, B Ivanoff, JD Clemens, DL Swerdlow, ...
Bulletin of the World Health Organization 77 (8), 651, 1999
16091999
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
RB Belshe, PM Mendelman, J Treanor, J King, WC Gruber, P Piedra, ...
New England Journal of Medicine 338 (20), 1405-1412, 1998
11531998
Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine
LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ...
New England Journal of Medicine 384 (5), 403-416, 2021
10052021
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
C Troeger, M Forouzanfar, PC Rao, I Khalil, A Brown, RC Reiner Jr, ...
The Lancet Infectious Diseases 17 (9), 909-948, 2017
964*2017
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review …
T Shi, DA McAllister, KL O'Brien, EAF Simoes, SA Madhi, BD Gessner, ...
The Lancet 390 (10098), 946-958, 2017
9222017
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium
W Checkley, AC White Jr, D Jaganath, MJ Arrowood, RM Chalmers, ...
The Lancet Infectious Diseases 15 (1), 85-94, 2015
5872015
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
RB Belshe, WC Gruber, PM Mendelman, I Cho, K Reisinger, SL Block, ...
The Journal of pediatrics 136 (2), 168-175, 2000
5202000
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology
L Von Seidlein, DR Kim, M Ali, H Lee, XY Wang, VD Thiem, W Chaicumpa, ...
PLoS Med 3 (9), e353, 2006
5152006
Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study
J Liu, JA Platts-Mills, J Juma, F Kabir, J Nkeze, C Okoi, DJ Operario, ...
The Lancet 388 (10051), 1291-1301, 2016
4712016
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
RB Belshe, WC Gruber, PM Mendelman, HB Mehta, K Mahmood, ...
The Journal of infectious diseases 181 (3), 1133-1137, 2000
4482000
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults
P Michetti, C Kreiss, KL Kotloff, N Porta, JL Blanco, D Bachmann, ...
Gastroenterology 116 (4), 804-812, 1999
3661999
2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea
AL Shane, RK Mody, JA Crump, PI Tarr, TS Steiner, K Kotloff, JM Langley, ...
Clinical Infectious Diseases 65 (12), e45-e80, 2017
3402017
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
MM Levine, KL Kotloff, EM Barry, MF Pasetti, MB Sztein
Nature Reviews Microbiology 5 (7), 540-553, 2007
3362007
Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with …
JJ Treanor, K Kotloff, RF Betts, R Belshe, F Newman, D Iacuzio, J Wittes, ...
Vaccine 18 (9-10), 899-906, 1999
2961999
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study
KL Kotloff, WC Blackwelder, D Nasrin, JP Nataro, TH Farag, A van Eijk, ...
Clinical infectious diseases 55 (suppl_4), S232-S245, 2012
2792012
Intra-and interseasonal autoregressive prediction of dengue outbreaks using local weather and regional climate for a tropical environment in Colombia
MD Eastin, E Delmelle, I Casas, J Wexler, C Self
The American journal of tropical medicine and hygiene 91 (3), 598-610, 2014
234*2014
Safety and Immunogenicity of Oral Inactivated Whole-CellHelicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection
KL Kotloff, MB Sztein, SS Wasserman, GA Losonsky, SC DiLorenzo, ...
Infection and immunity 69 (6), 3581-3590, 2001
2282001
Measurement of fecal lactoferrin as a marker of fecal leukocytes.
RL Guerrant, V Araujo, E Soares, K Kotloff, AA Lima, WH Cooper, AG Lee
Journal of clinical microbiology 30 (5), 1238-1242, 1992
2251992
Phase 2 clinical trial of attenuatedSalmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers
CO Tacket, MB Sztein, SS Wasserman, G Losonsky, KL Kotloff, TL Wyant, ...
Infection and immunity 68 (3), 1196-1201, 2000
2202000
The system can't perform the operation now. Try again later.
Articles 1–20